Peer-reviewed publications
  1. Anderson WC, Gondalia R, Hoch HE, Kaye L, Barrett M, Szefler SJ, et al. Assessing asthma control: Comparison of electronic-recorded short-acting beta-agonist rescue use and self-reported use utilizing the Asthma Control Test. J Asthma. 2019;1–8
  2. Chen J, Kaye L, Tuffli M, Barrett MA, Jones-Ford S, Shenouda T, et al. Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis. JMIR Form Res. 2019;3:e13286. (Link)
  3. Gondalia R, Bender BG, Theye B, Stempel DA. Higher short-acting beta-agonist use is associated with greater COPD burden. Respir Med. 2019;158:110–3. (Link)
  4. Hynes L, Durkin K, Williford DN, Smith H, Skoner D, Lilly C, et al. Comparing Written Versus Pictorial Asthma Action Plans to Improve Asthma Management and Health Outcomes Among Children and Adolescents: Protocol of a Pilot and Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2019;8:e11733–e11733. (Link)
  5. Mehta P, Pan Z, Furuta GT, Kwan BM. Mobile health tool detects adherence rates in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2019; (Link)
  6. Alshabani K, Attaway AA, Smith MJ, Majumdar U, Rice R, Han X, et al. Electronic inhaler monitoring and healthcare utilization in chronic obstructive pulmonary disease. J Telemed Telecare. 2019; (Link)
  7. Mosnaim G, Stempel H, Szefler SJ, Stempel DA. Asthma Control — Time to Rethink Definitions and Criteria. J Allergy Clin Immunol Pract. 2019;7:1522–3. (Link)
  8. Anderson WC, Gondalia R, Hoch HE, Kaye L, Szefler SJ, Stempel DA. Screening for inhalation technique errors with electronic medication monitors. J Allergy Clin Immunol Pract. 2019; (Link)
  9. Merchant R, Szefler SJ, Bender BG, Tuffli M, Barrett MA, Gondalia R, et al. Impact of a digital health intervention on asthma resource utilization. World Allergy Organ J. 2018;11:28. (Link)
  10. Williams AM, Phaneuf DJ, Barrett MA, Su JG. Short-term impact of PM2.5 on contemporaneous asthma medication use: Behavior and the value of pollution reductions. Proc Natl Acad Sci. 2019;116:5246 LP – 5253. (Link)
  11. Szefler SJ, Hoch HE, Tuffli M, Gondalia R, Barrett MA, Van Sickle D, et al. Quantifying beta-agonist utilization: Occasions or puffs? J Allergy Clin Immunol Pract. 2019;7:1088–90. (Link)
  12. Merchant R, Inamdar R, Henderson K, Barrett M, Su GJ, Riley J, et al. Digital Health Intervention for Asthma: Patient-Reported Value and Usability. JMIR Mhealth Uhealth. (Link)
  13. Barrett M, Combs V, Su JG, Henderson K, Tuffli M. AIR Louisville: Addressing Asthma With Technology, Crowdsourcing, Cross-Sector Collaboration, And Policy. Health Aff. 2018;37:525–34. (Link)
  14. Van Sickle D, Barrett MA. Transforming Global Public Health Using Connected Medicines. Respir Drug Deliv. 2018;1:61–70. (Link)
  15. Hoch H, Kempe A, Brinton J, Szefler S. Feasibility of medication monitoring sensors in high risk asthmatic children. J Asthma. 2018;56:270–2. (Link)
  16. Magzamen S, Oron AP, Locke ER, Fan VS. Association of ambient pollution with inhaler use among patients with COPD: a panel study. Occup Environ Med. 2018;75:382 LP – 388. (Link)
  17. Barrett MA, Humblet O, Marcus JE, Henderson K, Smith T, Eid N, et al. Effect of a mobile health, sensor-driven asthma management platform on asthma control. Ann Allergy, Asthma Immunol. 2017;119:415-421.e1. (Link) (PDF)
  18. Sumino K, Locke ER, Magzamen S, Gylys-Colwell I, Humblet O, Nguyen HQ, et al. Use of a Remote Inhaler Monitoring Device to Measure Change in Inhaler Use with Chronic Obstructive Pulmonary Disease Exacerbations. J Aerosol Med Pulm Drug Deliv. 2017;jamp.2017.1383. (Link) (PDF)
  19. Adams SA, Leach MC, Feudtner C, Miller VA, Kenyon CC. Automated Adherence Reminders for High Risk Children With Asthma: A Research Protocol. JMIR Res Protoc. 2017;6:e48. (Link)
  20. Son J, Brennan PF, Zhou S. Correlated gamma-based hidden Markov model for the smart asthma management based on rescue inhaler usage. Stat Med. 2017;36:1619–37. (Link)
  21. Su JG, Barrett MA, Henderson K, Humblet O, Smith T, Sublett JW, et al. Feasibility of Deploying Inhaler Sensors to Identify the Impacts of Environmental Triggers and Built Environment Factors on Asthma Short-Acting Bronchodilator Use. Environ Health Perspect. 2016/06/24. 2017;125:254–61. (Link) (PDF)
  22. Merchant RK, Inamdar R, Quade RC. Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2016;4:455–63. (Link) (PDF)
  23. Fan VS, Gylys-Colwell I, Locke E, Sumino K, Nguyen HQ, Thomas RM, et al. Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability. Respir Med. 2016;116:100–6. (Link) (PDF)
  24. Kim MS, Henderson KA, Van Sickle D. Using Connected Devices to Monitor Inhaler Use in the Real World. Respir Drug Deliv. 2016;1:37–44. (Link) (PDF)
  25. Van Sickle D, Maenner MJ, Barrett MA, Marcus JE. Monitoring and Improving Compliance and Asthma Control: Mapping Inhaler Use for Feedback to Patients, Physicians and Payers. Respir Drug Deliv. 2013;1:119–30. (Link) (PDF)
  26. Van Sickle D, Magzamen S, Truelove S, Morrison T. Remote monitoring of inhaled bronchodilator use and weekly feedback about asthma management: an open-group, short-term pilot study of the impact on asthma control. Baradaran HR, editor. PLoS One. 2013;8:e55335. (Link) (PDF)
Non peer-reviewed publications
  1. Henderson et al. 2015. Citizen Health Scientists For Chronic Disease: From Disease Management in Isolation to the Power of the Community in Louisville and Beyond. Sustain 33. (PDF)
  2. Van Sickle et al. 2014. Leveraging digital health technology: Five ways to address barriers to inhaled medication adherence. Inhalation. (PDF)
Peer-reviewed abstracts
  1. Gondalia R, Anderson W, Hoch H, Szefler S, Stempel D. Prevalence of short-acting beta-agonist (SABA) along and in conjunction with inhaled corticosteroids (ICS). Ann Allergy, Asthma Immunol. 2019;123:S42. (Link)
  2. Bender BG, Gondalia R, Stempel DA. Longitudinal trends in inhaled maintenance medication adherence in a digital health program varied by age and COPD Assessment Test score. Chest. 2019;156.
  3. Casey J. Symposium on Quasi-experimental designs. A multi-level analysis of the impact of changes in coal-fired power plant emissions on asthma-related healthcare utilization and symptoms in Louisville, Kentucky. Utrecht, Netherlands. Int Soc Environ Epidemiol. 2019 (Link)
  4. Hoch H, Gondalia R, Anderson W, Barrett M, Szefler S, Van Sickle D, et al. Trends of short-acting beta-agonist (SABA) surrounding days of high use in asthma and COPD. Eur Respir J. 2019;54:OA5350. (Link)
  5. Anderson W, Gondalia R, Hoch H, Barrett M, Szefler S, Van Sickle D, et al. Nighttime short-acting beta-agonist (SABA) in asthma and COPD. Eur Respir J. 2019;54:PA859. (Link)
  6. Anderson WC, Hoch HE, Gondalia R, Kaye L, Szefler SJ, Stempel DA. Real-life Patterns of Short-Acting Beta-Agonist Use in Patients with COPD Vary by Time of Day and Season. Am J Respir Crit Care Med. 2019;A5933–A5933. (Link)
  7. Theye B, Gondalia R, Stempel DA. Monitoring Daily Maintenance Medication Adherence in Patients with COPD. Am J Respir Crit Care Med. 2019;A2986–A2986. (Link)
  8. Anderson W, Hoch H, Gondalia R, Kaye L, Szefler SJ, Stempel DA. Digital assessment of asthma controller and rescue medication use as children transition into adulthood. J Allergy Clin Immunol. 2019;143:AB91. (Link)
  9. Zhu L, Ramirez Y, Villalobos-Terrazas D, Reyes K, BenIsrael-Olive N, Gondalia R, et al. Aligning Guideline Criteria for Asthma Control with Digitally Collected Data. J Allergy Clin Immunol. 2019;143:AB171. (Link)
  10. Parikh S, Kaye L, Gondalia R, Barrett M, Henderson K, Stempel D. Social Connectedness and Associated Digital Health Solutions in the COPD Patient Population: A Systematic Review. In: Annals of Behavioral Medicine. 2019. p. S538–S538. (Link)
  11. Henderson K, Gondalia R, Kaye L, Remmelink E, Barrett M. COPD Patient Experience and Use of a Digital Health Platform. In: Annals of Behavioral Medicine. 2019. p. S303–S303. (Link)
  12. Kaye L, Henderson K, Barrett M, Theye B, Gondalia R. Smartphone App Features Associated with Controller Inhaler Use Among Adults with Asthma. In: Annals of Behavioral Medicine. 2019. p. S259–S259. (Link)
  13. Blumenstock J, Boon K, Kanaley M, Szkodon J, Newmark P, Bozen A, et al. Caregiver Quality of Life and Management Self-Efficacy in a Technology-Based Asthma Medication Monitoring Clinical Trial. Ann Allergy, Asthma Immunol. 2018;121:S45. (Link)
  14. Kaye L, Hoch H, Szefler SJ, Anderson W, Barrett M, Van Sickle D, et al. Real-Life Patterns of Asthma Controller Use Vary by Age, Time of Day and Season. J Allergy Clin Immunol. 2018;141:AB61. (Link)
  15. Anderson W, Brinton J, Kaye L, Hoch H, Barrett M, Van Sickle D, et al. Real-Life Patterns of Short-Acting Beta-Agonist Use in Persistent Asthmatics Vary by Age, Time of Day, and Season. J Allergy Clin Immunol. 2018;141:AB61. (Link)
  16. Ramirez E, Yeung D, Barrett M, Parson L, Simrall G. Public/Private Partnerships for Public Health: Lessons from the Santa Monica Wellbeing Project and AIR Louisville. Ann Behav Med. 2018;52:S427. (Link)
  17. Anderson W, Hoch H, Gondalia R, Kaye L, Theye B, Barrett M, et al. Frequency of improper inhaler technique identified by electronic medication monitor (EMM) actuation timing. Ann Allergy, Asthma Immunol. 2018;121:S7–8. (Link)
  18. Gondalia R, Theye B, Stempel DA. The Association of Digitally Collected Short-Acting Beta-Agonist and Maintenance Medication Use and COPD Assessment Test. Am J Respir Crit Care Med. 2019;A5932–A5932. (Link)
  19. Hoch H, Kaye L, Gondalia R, Theye B, Barrett M, Van Sickle D, et al. Benefit of smartphone alerts to improve adherence to inhaled to inhaled asthma controllers. Ann Allergy, Asthma Immunol. 2018;121:S40. (Link)
  20. Carl JC, Isakov D, Winners S, Lucik T, Ferchau A, Antara A, et al. Use of Remote Electronic Monitoring Improves Asthma Outcomes Through Improved Adherence. Am J Respir Crit Care Med. 2018;A1164–A1164.
  21. Henderson K, Barrett M, Williams M. Evaluation of the impact of a digital health platform on asthma self-management e. Ann Behav Med. 2018;52:S729. (Link)
  22. Alshabani K, Smith M, Attawy A, Rice R, Wang X, Han X, et al. Reduction in COPD Related Healthcare Utilization with Use of Electronic Inhaler Monitoring. Am J Respir Crit Care Med. 2018;A4560–A4560. (Link)
  23. Alshabani K, Smith M, Attawy A, Rice R, Wang X, Han X, et al. Trends in Long-Acting Bronchodilator Adherence During Electronic Inhaler Monitoring. American Journal of Respiratory and Critical Care Medicine. 2018;A4558–A4558. (Link)
  24. Anderson WC, Hoch H, Kaye L, Tuffli M, Barrett M, Van Sickle D, et al. Association Between Objective Short-Acting Beta-Agonist Use and Self-Reported Asthma Control Test Scores Among Adults with Asthma [Internet]. American Journal of Respiratory and Critical Care Medicine. American Thoracic Society; 2018. p. A4834–A4834. (American Thoracic Society International Conference Abstracts). (Link)
  25. Hoch H, Anderson WC, Tuffli M, Kaye L, Barrett M, Van Sickle D, et al. Using Digital Technology to Identify Adherence Phenotypes May Identify Appropriate Time for Intervention. Am J Respir Crit Care Med. 2018;A4855–A4855. (Link)
  26. Anderson W, Hoch H, Gondalia R, Kaye L, Barrett M, Van Sickle D, et al. Asthma control evaluated with electronic medication monitor (EMM)-defined occasions of short-acting beta-agonist inhaler use. Ann Allergy, Asthma Immunol. 2018;121:S40. (Link)
  27. och H, Kaye L, Anderson W, Gondalia R, Barrett M, Tuffli M, et al. Comparing objective inhaler use among COPD and Asthma populations. Eur Respir J. 2018;52:PA2272. (Link)
  28. Cardet JC, Busse PJ, Carroll JK, Casale TB, Coyne-Beasley T, Fagan M, et al. Adherence to Adding ICS to Rescue Therapy in a Pragmatic Trial with Adults with Asthma– a Pilot Study. J Allergy Clin Immunol. 2018;141:AB209. (Link)
  29. Hoch H, Anderson WC, Gondalia R, Kaye L, Szefler SJ, Stempel DA. Digitally Recorded Controller and Rescue Medication Use Vary by Age in Patients with Asthma. Am J Respir Crit Care Med. 2019;A5931–A5931. (Link)
  30. Chen J, Jones-Ford S, Goeldi S, Barrett MA, Van Sickle D. Feasibility and Clinical Impact of Deploying a Digital Health Intervention on a Medicare Population with Asthma or Chronic Obstructive Pulmonary Disease (COPD). Am J Respir Crit Care Med. 2017;A1722–A1722. (Link)
  31. Merchant R, Tuffli M, Barrett M, Hogg C, Van Sickle D, Stempel D. Impact of A Digital Health Intervention On Asthma Healthcare Utilization. Eur Respir J. 2017;50:PA4692. (Link)
  32. Pepper J, Merchant R, Su J, Barrett M, Henderson K, Stempel D, et al. Evaluating asthma short-acting beta agonist use and outdoor air pollution: A geospatial-temporal analysis. Am Public Heal Assoc. 2017;
  33. Hoch H, Kempe A, Brinton J, Szefler S. Assessing the utility of asthma medication monitoring sensors in a group of high risk asthmatic children. Eur Respir J. 2017;50:PA598. (Link)
  34. Su J, Barrett M, Henderson K, Smith T, Combs V, Goeldi S, et al. Leveraging wireless inhaler sensors to estimate the impact of rising temperatures and pollutant levels on asthma symptoms. Am Public Heal Assoc. 2017; (Link)
  35. Hoch H, Meier MR, Brinton JT, Szefler SJ. A Feasibility Study of Daily Monitoring of Controller and Rescue Medication Use in a Pediatric Patient Population at High Risk of an Asthma Exacerbation. Am J Respir Crit Care Med. 2017;A2198–A2198. (Link)
  36. Merchant R, Inamdar R, Henderson K, Barrett MA, Van Sickle D. Digital Health Intervention for Asthma: Patient Perception of Usability and Value for Self-Management. Am J Respir Crit Care Med. 2017;A3326–A3326.
  37. Merchant R, Tuffli M, Barrett M, Hogg C, Van Sickle D. Interim Results of the Impact of a Digital Health Intervention on Asthma Healthcare Utilization. J Allergy Clin Immunol. 2017;139:AB250. (Link)
  38. Chen J, Jones-Ford S, Goeldi S, Tuffli M, Barrett M, Van Sickle D, et al. Feasibility and clinical impact of deploying a digital health intervention in a Medicare population with COPD. Eur Respir J. 2017;50:PA390. (Link)
  39. Stempel D, Szefler S, Hoch H, Tuffli M, Barrett M, Van Sickle D. Daily pattern of ß2-agonists: understanding real-life use of rescue medication. Eur Respir J. 2017;50:PA3959. (Link)
  40. Stanford RH, Averell CM, Johnson P, Buysman E, Carlyle M. Adherence and Asthma Control in Patients Using FF/VI with and Without a Clip-On Sensor That Monitors Adherence. Am J Respir Crit Care Med. 2019;A5930–A5930. (Link)
  41. Su J, Barrett M, Henderson K, Humblet O, Hogg C, Van Sickle D, et al. Identification of asthma short-acting bronchodilator use in space and time using mobile health tools. Am Assoc Geogr. 2016; (Link)
  42. Su J, Barrett M, Humblet O, Smith T, Hogg C, Henderson K, et al. Identifying Environmental Drivers of Asthma Hotspots using Real-Time Inhaler Sensors. Natl Assoc Chronic Dis Dir. 2016;
  43. Smith T, Van Sickle D, Barrett M, Henderson K, Humblet O, Hogg C, et al. Improving the Burden of Respiratory Disease Through Data-Driven Innovation: The AIR Louisville Program in Jefferson County, Kentucky. Am J Respir Crit Care Med. 2016;A1750–A1750. (Link)
  44. Van Sickle D, Barrett M, Humblet O, Su J, Henderson K, Smith T. Impact of a Mobile Health and Sensor-Driven Asthma Management Pilot Study on Symptoms, Control, and Self-Management. J Allergy Clin Immunol. 2016;137:AB9. (Link)
  45. Su J, Barrett M, Henderson K, Humblet O, Smith T, Veronica C, et al. Application of wireless inhaler sensors to enhance asthma surveillance and inform municipal interventions. Am Public Heal Assoc. 2016; (Link)
  46. Van Sickle D, Barrett M, Humblet O, Henderson K, Hogg C. Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence. Eur Respir J. 2016;48:PA1018. (Link)
  47. Merchant R, Inamdar R, Henderson K, Barrett M, Van Sickle D. Patient Reported Value and Usability of a Digital Health Intervention for Asthma. JMIR Iproceedings. 2016;2:e36. (Link)
  48. Van Sickle D, Su J, Barrett M, Humblet O, Henderson K, Smith T. Impact of a mobile health pilot study on asthma rescue inhaler use, control and self-management. Eur Respir J. 2015;46:PA2528. (Link)
  49. Sumino K, Locke E, Magzamen S, Thomas R, Gylys-Colwell I, Nguyen HQ, et al. Use of a Remote Inhaler Monitor Device to Measure Change in Inhaler Use with COPD Exacerbations. Am J Respir Crit Care Med. 2015;A6181–A6181. (Link)
  50. Barrett M, Van Sickle D, Hogg C, Su J, Humblet O, Henderson K, et al. Identifying environmental drivers of asthma hotspots in Louisville, Kentucky, using sensors to capture spatially-explicit, real-time data on inhaler use: AIR Louisville program. Am Public Heal Assoc. 2015; (Link)
  51. Stanford RH, Averell CM, Johnson P, Buysman E, Carlyle M. Controller Adherence and Albuterol Use Among Adult Patients with Asthma on Once or Twice Daily Ics/laba Therapy Using Clip-on Sensor Technology to Assess Outcomes. Am J Respir Crit Care Med. 2019;A5929–A5929. (Link)
  52. Van Sickle D. Recent Advances in Digital Health Tools for Asthma and COPD Management in Underserved Populations. In: American Thoracic Society. Denver, CO; 2015.
  53. Smith T, Marcus J, Barrett M, Humblet O, Van Sickle D. Technology-driven asthma data program to inform regional policy: The municipal perspective. Am Public Heal Assoc. 2014; (Link)
  54. Van Sickle D, Barrett M, Marcus J, Humblet O, Smith T. Impact of a technology-driven asthma program on symptoms, control and self-management: The clinical perspective. Am Public Heal Assoc. 2014; (Link)
  55. Merchant R, Inamdar R, Quade R, Van Sickle D, Humblet O, Marcus J, et al. Interim Results From A Randomized, Controlled Trial Of Remote Monitoring Of Inhaled Bronchodilator Use On Asthma Control, Symptoms And Management. Am J Respir Crit Care Med. 2014;A1386–A1386. (Link)
  56. Barrett M, Humblet O, Marcus J, Smith T, Van Sickle D. Exploring drivers of asthma in Louisville with spatially-explicit, real-time data: The environmental perspective. Am Public Heal Assoc. 2014; (Link)
  57. Nesbitt L, Barrett M, Humblet O, Marcus J, Smith T, Van Sickle D. Technology-driven asthma data can support surveillance efforts: The public health perspective. Am Public Heal Assoc. 2014; (Link)
  58. Van Sickle D, Smith T, Barrett M. Louisville asthma data initiative – a municipal digital health program to improve self-management and public health surveillance of asthma. Am Public Heal Assoc. 2013; (Link)
  59. Merchant R, Inamdar R, Quade R, Van Sickle D, Maenner M, Patmas M. Interim Results From a Randomized, Controlled Trial of Remote Monitoring of Inhaled Bronchodilator Use on Asthma Control and Management. Chest. 2013;144:71A. (Link)
  60. Van Sickle D, Morrison TA. Weekly Feedback Summarizing Use Of Remotely Monitored Rescue Medication Improves Asthma Control. Am J Respir Crit Care Med. 2011;A4755–A4755. (Link)
  61. Van Sickle D, Magzamen S, Truelove S. Online Feedback About Remotely Monitored Inhaled Bronchodilators Improves Composite Measures Of Asthma Control. Am J Respir Crit Care Med. 2010;A3127–A3127. (Link)
  62. Hoch H, Meier M, Brinton J, Szefler SJ. Breathing Counts: Addressing Barriers to Medication Use in High Risk Children with Asthma. Am J Respir Crit Care Med. 2019;A7178–A7178. (Link)
  63. Van Sickle D. Development of a Networked Asthma Inhaler To Improve Clinical Management and Public Health Surveillance. Am J Respir Crit Care Med. 2009;A4065. (Link)
  64. Hoch H, Pickett K, Brinton J, Szefler SJ. Evaluating Adherence Data in the Clinical Setting: What Tools Should We Use to Describe Behavior? Am J Respir Crit Care Med. 2019;A6735–A6735. (Link)
  65. Alshabani K, Smith M, Majumdar U, Attaway A, Rice R, Han X, et al. Prediction of COPD Exacerbations with Electronic Inhaler Monitoring. Am J Respir Crit Care Med. 2019;A5647–A5647. (Link)
  66. Gondalia R, Anderson W, Hoch H, Kaye L, Szefler SJ, Stempel DA. Assessing the sensitivity and specificity of self-reported short-acting beta agonist (SABA) inhaler use with electronic medication monitors (EMMs). J Allergy Clin Immunol. 2019;1431:AB169. (Link)